ENUM selling off there "intellectual property isn't anything new here.
Pieris Pharmaceutical(PIRS) on the NYSE which is trading around 4.72, has had an agreement with Enumeral to buy their PD-1 antibody. They couldn't get anything done by May 31 so the deal was terminated.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.